Straightforward methods for the introduction of stable isotopes into proteins with subsequent isolation and purification of the proteins will greatly aid the field of quantitative proteomics. Proteins containing amino acids with one or more of the stable isotopes of deuterium, O can be used as internal standards by addition at an early stage of analysis of a complex protein sample and subsequent measurement using mass spectrometry. There are two approaches for introducing a stable isotope into a protein without chemically modifying that protein, metabolic labeling using whole cells grown in culture, or cell-free labeling using a lysate of either Escherichia coli or wheat germ. Each approach has its advantages and disadvantages which will be discussed. Particular attention will be paid to the cell-free method using an E. coli lysate.
INTRODUCTION
The field of proteomics has benefited greatly from the ability to introduce stable isotopes into proteins and peptides. Isotopic labeling in the context of this discussion refers to the introduction of a naturally low-abundance isotope of carbon, nitrogen, hydrogen and, in some cases, oxygen, into a peptide or protein. The isotopes commonly used are 13 C, 15 N, 2 H (deuterium) and 18 O with natural abundances of 1.10%, 0.366%, 0.015% and 0.200%, respectively [1] . Therefore, the introduction of these isotopes into a peptide or protein is tantamount to the introduction of a label which can be readily detected by most modern mass spectrometers that are capable of providing unit resolution across the mass range usually employed.
The application of isotopically labeled proteins has been most evident in the area of comparative proteomics (or differential proteomics) where two samples are compared, one labeled with the naturally occurring isotope abundance (light) and the other with a stable isotope of low natural abundance (heavy). The samples are mixed and analyzed by mass spectrometry. The determination of the ratio of heavy to light then allows a comparative analysis of the relative amounts of a given protein in the two samples. Such results are unaffected by instrument response, sample losses during workup, purity and other factors that can complicate quantitative analysis.
Several approaches have been taken to introduce stable isotopes into proteins. Probably the most widely applied method is metabolic labeling where cells are grown in culture in the presence of labeled precursors. Another method that is gaining in acceptance is the cell-free approach, where lysates are prepared from whole cells and are often supplemented with components to facilitate the synthesis of proteins. When these cell-free reactions are carried out in the presence of labeled amino acids, these amino acids are incorporated into the protein. Finally, chemical methods have been employed to introduce label into proteins. These chemical methods include the so-called ICAT (isotope-coded affinity tag) procedure [2] , acrylamide labeling [3] , 18 O-labeling during proteolysis [4, 5] and guanidination of lysine residues [6, 7] . This review will cover the topic of introducing an isotope into a protein followed by purification of that protein. The reason for doing this is to prepare purified, isotopically labeled proteins that can be used as internal standards in a more classical analytical approach to quantitative proteomics. The internal standard is added to a sample at the beginning of sample preparation and carried through all of the steps of sample preparation to mass spectrometric analysis.
The first application of stable isotopically labeled internal standards was with peptides [8] , primarily due to the ease of incorporation of isotopically labeled amino acids into peptides through solid-state peptide synthesis [9] . Only recently have isotopically labeled proteins been used for absolute protein quantification [10] . However, there are significant advantages to the use of whole proteins instead of peptides for this purpose, notably the advantage of the internal standard being chemically identical to the analyte being measured, and the ability to add this internal standard to the crude sample prior to workup for analysis to control for changes or losses of the analyte during this process.
Two methods will be discussed for the preparation of purified, isotopically labeled proteins: metabolic labeling using whole cells and the cell-free approach using cell lysates. Metabolic labeling or cell-based protein labeling will be mentioned briefly with the focus of this article on the cell-free approach. The cell-based approach has been the topic of many excellent reviews and the reader is referred to a recent review by Benyon and Pratt [11] .
LABELED PRECURSORS
Whether using a cell-based approach or a cell-free approach, a protein precursor containing the stable isotope is used. For both approaches, isotopically labeled amino acids may be used. Amino acids with high abundances of stable isotopes are commercially available from several vendors. A list of such amino acids, taken from the online catalog of one of the vendors, is shown in Table 1 . All 20 of the L-amino acids commonly found in proteins are available with a variety of stable isotopes incorporated. All of the amino acids are available with either a single or double label of 13 C, 15 N or 2 H, and most of them are also available with three isotopes. There is even one amino acid with an 18 O label. This list has grown considerably in the last few years and as more types of proteomic experiments are conceived of, it is likely that other labeled amino acids, not currently available, will become available.
For cell-based approaches, which can take advantage of the cellular biochemical pathways, simpler, less expensive alternatives are available. Specially formulated culture media, optimized for different cell types, including Escherichia coli, insect cells, yeast and mammalian cells, are now commercially available (Table 2) . Furthermore, several different isotopically labeled reagents, suitable for use as carbon or nitrogen sources in culture media are also commercially available (Table 3) .
CELL-BASED PROTEIN LABELING
The utility of cell-based systems for the introduction of isotopes into proteins is well established. All cell-based approaches rely on the metabolic conversion of labeled precursors into protein. The labeled precursors may be amino acids which can be incorporated directly into protein or they may be more fundamental precursors which serve as carbon or nitrogen sources for the synthesis of amino acids prior to incorporation into protein.
Most cell-based labeling experiments using stable isotopes have been used for the purpose of comparative proteomics. Given the acronym SILAA (stable isotope labeling with amino acids) [12] or SILAC (stable isotope labeling by/with amino acids in cell culture) [13, 14] , the experimental approach is generally to label two different cultures of cells exposed to different experimental conditions with either 12 C or 13 C amino acids, mix equal amounts of the two cultures and perform a proteomics experiment. Measurement of the ratio of 12 C-labeled tryptic peptides to the corresponding 13 C-labeled peptides provides a relative determination of the protein produced under the biological condition being studied.
The same general approach for the introduction of a stable isotope into a protein can be used to produce labeled protein for subsequent use in proteomics experiments.
A wide variety of different cell types, both prokaryotic and eukaryotic, has been used for the production of isotopically labeled proteins. Generally, the choice of cell type used depends on the complexity of the protein, the amount of protein required and the cell that can be best programmed to overexpress a gene encoding the protein of interest.
The advantages and disadvantages of cell-based protein labeling are presented in Table 4 . While the approach is relatively easy and can result in large amounts of labeled protein being produced, there are several disadvantages, as well, to this approach. Cell culture in general requires specialized equipment and, depending on the type of cell used, may include incubators, shakers and centrifuges. 
(U-13C11, 98%; U-D8, 98%; U-15N2, 98%) Glycine, Ethyl Ester In addition, sterile conditions must be maintained and, certainly when working with mammalian cells, a laminar flow hood is necessary to manipulate the cell culture and maintain sterile conditions.
Although cell culture results in the production of large amounts of protein, it must be kept in mind that all protein that the cell produces, not just the recombinant protein that the cell is programmed to overexpress, will incorporate the label. Depending on the expression level of the protein of interest, this can lead to significant purification issues. Since all the cellular protein incorporates label, even low amounts of contaminating protein in a purified protein of interest can influence the interpretation of a subsequent experiment in which that protein is used. Additional purification steps can substantially increase the cost of producing the labeled protein.
Other disadvantages that should be considered when contemplating the use of a cell-based system to produce labeled protein include incomplete labeling, metabolic lability of amino acid precursors and protein turnover.
CELL-FREE PROTEIN LABELING
Cell-free protein synthesis systems were first developed in the late 1950s and early 1960s. These early cell-free systems were typically cell lysates that retained the ability to synthesize proteins programmed by endogenous mRNA found in the ribosomes Table 2 : Labeled media for cell-based protein production 
These products are available from Cambridge Isotope Laboratories. These amino acids are available from one of the vendors, Cambridge Isotope Laboratories, which supplies such products and is taken from their online catalog. All of the common amino acids found in proteins are available with a variety of labeling patterns.The table lists the amino acids and amino acid derivatives and indicates the stable isotope present, the labeling pattern and the isotopic abundance. of the lysates [15] [16] [17] . A major advance in cell-free protein synthesis occurred in the early 1960s when Nirenberg and Matthiei [18] were able to remove endogenous mRNA by preincubation of an E. coli cell extract. This pretreated extract could then be programmed by adding exogenous mRNA or even synthetic polynucleotides, making the system much more versatile and providing the ability to synthesize proteins of interest. It was not until the 1970s, however, that an efficient widely used, cell-free system, derived from rabbit reticulocyte lysates, was developed [19] . About the same time as the rabbit reticulocyte system was being developed, another eukaryotic system, the wheat germ extract was also introduced [20, 21] . The wheat germ system, due to low levels of endogenous mRNA, could be used for the expression of exogenous mRNA without pretreatment of the extract.
The true utility of the cell-free approach was achieved when a system was developed coupling the process of DNA transcription and the process of mRNA translation. This coupled transcription/ translation system enabled the production of desired protein products from DNA templates [22, 23] .
The history of the development of various cellfree translation and transcription/translation systems has been reviewed in detail by Spirin [24] and the reader is referred to this chapter for additional information.
Cell-free translation systems are generally supernatants obtained by centrifugation of the crude lysate of either E. coli, wheat germ or rabbit reticulocytes at 30 000g (referred to as the S30 fraction). The S30 fraction contains the cell's protein synthetic machinery consisting of ribosomes, translation factors, aminoacyl-tRNA synthetases and tRNAs. Oftentimes, supplementation of the S30 fraction with additional components, such as RNA polymerase, energy regeneration systems and various substrates leads to an enhancement of protein synthesis. Further improvement of this technology may come from the efforts to further fractionate and purify the components of the S30 fraction with the goal of assembling a completely defined system of individual components. Some work toward such a system has been performed [25] .
Two systems have been developed and optimized to the point of being capable of producing milligram quantities of protein, the E. coli system and the wheat germ system. However, the E. coli system is better understood and more widely used and will be the focus of this discussion.
Escherichia coli system
A commercially available E. coli system is available from Roche Applied Science, Indianapolis, IN, USA. Known as RTS (rapid translation system), this coupled cell-free system has been optimized for protein synthesis driven by a DNA template. The RTS is a modular system consisting of the following components: (i) optimized E.coli lysate, (ii) reaction mix, (iii) feeding mix, (iv) amino acid mix and (v) supplements.
Components of system
Lysate The lysate is obtained by centrifugation of a crude E. coli lysate at 30 000g. This so-called S30 fraction contains the cell's protein synthetic machinery consisting of ribosomes, soluble enzymes, translation factors (including initiation-, elongation-and Amino acid pools likely diluted by newly synthesized amino acids. 5. Metabolic lability of amino acid precursors.
Amino acids can undergo metabolism during labeling process resulting in scrambling of the label. 6. Protein turnover.
Proteins produced during the labeling process will likely be degraded to a certain extent resulting in scrambling of the label.
termination factors), aminoacyl-tRNA synthetases and tRNAs.
Amino acid mix All 20 of the amino acids found in proteins must be added to the lysate to support protein synthesis. This is usually accomplished by preparing stock solutions of each amino acid and then blending these solutions to obtain the desired ratio of amino acids. This also allows the substitution of one or more isotopically labeled amino acids to achieve high-level incorporation of those labels into protein.
Since the cell-free system is dependent upon the addition of exogenous amino acids, it is possible to achieve extremely high levels of incorporation by using amino acid mixtures that are supplemented only with one or more labeled amino acid precursors.
Energy regenerating system
Cell-free protein synthesis requires an available supply of energy, in the form of ATP for activation of amino acids and GTP for ribosomal function. To meet this energy demand an ATP regeneration system is an important part of the cell-free system.
DNA templates
Depending on the mode of operation of the cell-free system, either linear or circular DNA templates may be used. In the batch mode both may be used, but in a larger scale continuous exchange cell-free mode (CECF) mode, circular templates are required to ensure template integrity throughout the course of the reaction. Using the RTS, certain key elements are required for protein synthesis: Since linear DNA templates are most commonly used in small-scale batch mode experiments, primarily for screening different DNA constructs, and not for production of large amounts of labeled proteins, they will not be further discussed.
Circular DNA templates
Circular DNA templates are generally used in the production of milligram quantities of labeled proteins. Although many different cloning vectors may be used successfully in the RTS, Roche Applied Science offers a series of vectors called pIVEX (plasmid for in vitro expression) cloning vectors which have been optimized for use in the RTS. These vectors containing the regulatory elements for in vitro expression shown in Figure 1 , use T7 RNA polymerase for DNA transcription. A multiple cloning site allows the insertion of a gene of interest for production of the corresponding protein. Table 5 shows a list of commercially available pIVEX vectors with different tags useful for purification or detection of protein product.
T7 polymerase
Even though bacterial lysates generally contain endogenous RNA polymerases, optimized cell-free systems are often supplemented with exogenous bacteriophage T7 RNA polymerase. 
Supplements
One of the advantages of a cell-free system is that it is an open system, that is, supplements may be added to the reaction mixture with the goal of enhancing expression, achieving proper folding of the protein or improving the solubility of the expressed protein.
The supplements most commonly used in cellfree protein expression are molecular chaperones and detergents. Chaperones which have been used successfully include GroE which includes GroEL and GroES, and the DNAJ/K/GrpE system. Chaperones have been the most useful in those situations where an expressed protein appears to have a folding problem. This is usually determined experimentally by taking early time points from a reaction and analyzing by SDS-PAGE. The analysis compares the total reaction mixture with a supernatant fraction obtained by centrifugation of the total reaction mixture. If more expressed protein is detected in the total reaction than in the supernatant, this is an indication of protein insolubility possibly due to improper folding of the protein and addition of a chaperone may facilitate the proper folding of the protein leading to greater solubility.
If the SDS-PAGE analysis indicates that the protein is soluble until the concentration of expressed protein has reached a certain level, then the solubility problem is probably due to exceeding the solubility of that protein under the conditions of the reaction. In such a case detergents may be useful in increasing the solubility of the protein. Many detergents have been tested and found to be useful in improving the expression yield of certain proteins. These proteins have been ionic (deoxycholic acid), nonionic (Brij 35, NP-40, Triton X-100 and others) and zwitterionic (Chaps, Zwittergent 3-12 and Zwittergent [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Success with detergents is protein dependent and usually requires screening of multiple detergents to find one that is beneficial to expression of the protein of interest.
Modes of operation
Cell-free systems can be operated in three different modes: batch mode, continuous flow cell-free (CFCF) mode and CECF mode.
Batch mode
As the name suggests, the reaction is carried out in a tube to which all components of the reaction are added. This method is useful for quickly and easily producing small amounts of protein. However, the necessary components are generally quickly depleted and inhibitory by-products rapidly accumulate resulting in a limited amount of protein production and rendering the approach unsuitable for the production of milligram quantities of protein. However, the batch mode is very useful for preliminary feasibility studies. Since expression levels vary greatly from protein to protein, a quick small-scale batch reaction can be used to estimate the expression level to see if it is worthwhile to proceed to the more costly production of larger amounts. While expression levels do not scale well, low expression in a small batch mode generally will indicate that production of larger amounts is not feasible.
Continuous flow cell-free mode
The CFCF mode of operation, first devised by Spirin and co-workers [26] , requires the continuous supply of fresh substrates and removal of by-products by a continuous flow of a feeding solution into a reaction chamber. The total volume of the reaction is constant so the volume flowing out of the chamber is equal to the volume flowing in. A convenient device to perform CFCF is an Amicon ultrafiltration device where the ultrafiltration membrane retains the high molecular weight components of the cell-free system, while allowing the low molecular weight substrates and by-products to freely cross the membrane.
Continuous exchange cell-free mode
The CECF mode of operation requires a system with two chambers, a reaction chamber where protein synthesis proceeds, and a feeding chamber which contains a supply of fresh substrates and the energy regenerating system. A diagram of a CECF device is shown in Figure 2 with a central reaction chamber surrounded by the feeding chamber. The two chambers are separated by a semi-permeable membrane that allows small molecules, such as amino acids and nucleotides to freely pass through the membrane but retains large molecules, such as enzymes, DNA and protein in the reaction chamber. Commercial devices constructed on the two chamber design are available but similar results can be obtained using a simple dialysis bag as the reaction chamber. The bag can be immersed in a feeding solution inside of a screw cap tube slightly larger than the dialysis bag creating a simple two chamber device.
Analysis and purification of protein products
Detection of protein synthesis in a cell-free system is generally accomplished by two different approaches. Although the cell-free system is programmed to produce only one, newly synthesized protein, the complexity of proteins present in the lysate complicate the detection of the newly synthesized protein, particularly when the protein is produced at relatively low levels. In this situation, detection of protein synthesis can easily be accomplished by western blot analysis of the crude reaction mixture. If the DNA template contains a tag (for example, the His 6 tag found in pIVEX2.4d) then a western blot using an anti-His 6 antibody can be used. The information from this western blot provides not only the evidence for synthesis of a specific protein product, but also molecular weight information about that protein. It is beyond the scope of this article to provide specific methods for performing western blot analyses and the reader is referred to a more detailed source, such as the RTS Application Manual for Cell-Free Protein Expression [27] , provided online by Roche Applied Science.
In those cases where protein expression is relatively high, detection of protein synthesis can often be achieved by a simple SDS-PAGE analysis of the reaction mixture.
Purification of the protein product of a cellfree reaction can be facilitated by the presence of a tag present in the protein product. For example, the His 6 tag, introduced by using either the pIVEX2.3d or pIVEX2.4d vectors, can be utilized in a purification scheme using immobilized metal affinity chromatography (IMAC) [28] on a nickel-nitrilotriacetic acid (Ni-NTA) column.
Generally, a second, polishing step, using size exclusion chromatography (SEC) will produce a protein product of sufficient purity for subsequent experimental applications. Figure 3 shows the analysis, by SDS-PAGE, of a protein, p38, produced in a cell-free system and purified by such a two-step procedure. Densitometric scanning of the purified protein estimated the purity of the p38 product to be >95%.
Examples of cell-free synthesis of labeled proteins
To illustrate the utility of the cell-free approach for the introduction of isotopic labels into protein, two experiments were performed. In the first experiment, the protein p38 was synthesized in the RTS using 15 N-glycine as the only source of glycine in the reaction mixture. As described earlier, the amino acid mixture was created using individual stock solutions of 19 of the amino acids and 15 N-glycine (Table 1 ) was added as the 20th amino acid. A gene encoding the protein p38 was cloned into the vector pIVEX2.4 which places a His 6 at the N-terminus of the protein. The plasmid was used in an RTS and the protein was produced at high level, estimated to be >1 mg/ml of reaction, and then purified using a two-step procedure consisting of affinity Figure 2 : Schematic diagram of a device used for the CECF mode of operation. The device consists of a reaction chamber, where the coupled transcription/ translation reactions of protein synthesis occur, separated from a feeding chamber by a semi-permeable membrane. The device allows fresh supplies of substrates for protein synthesis to enter the reaction chamber and also inhibitory by-products of protein synthesis to exit the reaction chamber. Figure 3 : SDS^PAGE analysis of the purification of the protein p38 produced in a cell-free reaction using the RTS. The protein was purified using a two-step procedure of affinity chromatography on a Ni-NTA column followed by SEC. Molecular weight markers are in the left lane and the purified protein in the right lane. The proteins are stained with Coomassie blue. Purity of the protein can be estimated by densitometric scanning of the stained gel.
chromatography on a Ni-NTA column followed by a size exclusion column. The purified protein was analyzed for incorporation of label by digestion with the protease trypsin and analysis of the resulting tryptic peptides by MALDI-TOF mass spectrometry.
The results of this analysis are shown in Figure 4 . One tryptic peptide, containing a single glycine residue, with the sequence Ile-Leu-Asp-Phe-GlyLeu-Ala-Arg, was analyzed and compared with the same tryptic peptide from a control reaction where the protein was not isotopically labeled. As expected, the isotopic cluster with the monoisotopic mass of 904.8 is shifted upon labeling by 1 mass unit. The efficiency of labeling can easily be estimated by comparing the peak heights of the ions corresponding to the unlabeled and the labeled proteins. In this example, the monoisotopic ion of the peptide ILDFGLAR is seen at m/z ¼ 904.6. A trace of this ion is seen in the spectrum of the labeled protein.
The monoisotopic ion corresponding to the peptide which has incorporated one glycine residue is seen at m/z ¼ 905.4. The ratio of the height of this ion to the total of the two ions in the labeled peptide gives an estimate of the labeling efficiency which, in this case, is 94%.
A second example of producing labeled protein is given in Figure 5 . The same protein, p38, was produced using the RTS, but, in this case, 13 C 4 -aspartic acid (Table 1 ) was added to the amino acid mixture as the only source of aspartic acid in the reaction. Each molecule of aspartic acid contains four atoms of 13 C and the isotopic purity is reported to be 98% ( Table 1) . As before, the labeled protein was purified using the same two-step purification procedure, and digested with the protease trypsin. An unlabeled control sample of p38 was included in the analysis. The MALDI-TOF mass spectrum of the control, unlabeled sample shows four tryptic peptides of p38 with masses (m/z) of 904.6, 1073.7, 1224.8 and 1526.9 ( Figure 5 , lower panel). In the labeled sample, corresponding tryptic peptides are seen at 908.6, 1077.6, 1228.7 and 1530.9. All these peptides represent a mass increment of 4 mass units, consistent with the starting, labeled amino acid, 13 C 4 -aspartic acid. The labeling efficiency in this example is more difficult to assess because of the busier spectrum, but does not appear to be as great as in the 15 N-glycine example presented above.
DISCUSSION
Both cell-based and cell-free methods are viable approaches for the production of isotopically labeled proteins. Each method has its advantages and disadvantages. Table 4 lists some of the advantages and disadvantages of cell-based protein production. Advantages include the relative ease of producing labeled proteins, but a cell culture facility, where sterile conditions can be maintained, is required. Another advantage is that the amount of protein that can be produced is limited only by the expression level of the protein of interest and the volume of cells that can be produced. The major disadvantage is that in cell culture all proteins, both the protein of interest and endogenous cellular protein will be labeled. This will likely complicate the purification process and may require more steps than two-step purification process discussed earlier. Other disadvantages are related to the cells' metabolic activity. Incomplete labeling may occur due to dilution of the pools of labeled amino acids with amino acids newly synthesized by the cell. In addition, turnover of both amino acids and proteins will potentially lead to scrambling of the label.
The advantages and disadvantages of cell-free systems are shown in Table 6 . With cell-free protein production systems, there is no need for cell culture or the facilities that are necessary to carry out cell culture work and no sterility concerns that are a necessary part of cell culture. One significant advantage of cell-free production is that only the protein of interest is labeled. Since the metabolic capability of whole cells is disrupted when the lysates are prepared, no biosynthesis of endogenous proteins takes place. Oftentimes, proteins that cannot be produced in whole cells, such as proteins toxic to the cell, can be produced in cell-free reactions. Different constructs can readily be screened by using PCR products in linear templates in small-scale batch reactions. This is a good method for evaluating different DNA constructs for those that give the optimal expression levels of the protein of interest. The primary disadvantage of the cell-free approach is the cost, particularly if the components of the cellfree system are purchased as commercial products.
The major advantage of using an isotopically labeled protein instead of a peptide in quantitative proteomics is in having an internal standard that is chemically identical to the analyte being measured. The labeled proteins can be added to the sample at an early stage, prior to any sample processing or depletion of abundant protein species, and thus will control for any losses of analyte during these steps. Labeled peptides are often added after these sample processing steps and cannot control for these losses. However, other issues must be considered when using labeled proteins as internal standards, notably, inconsistent proteolysis with trypsin. Protein secondary and tertiary structure or the presence of a purification tag at the N-or C-terminus can dramatically impact the efficiency of trypsin cleavage and the release of tryptic peptides. The obvious solution is to ensure that the protein internal standard is properly and correctly folded and is structurally identical to the endogenous protein.
The use of isotopically labeled proteins for protein structure determination by NMR spectroscopy is well established [29, 30] . However, there are relatively few references in the scientific literature to the While the system is far from simple, the actual application of the technology is straightforward and can be successfully applied by a skilled scientist without the use of special equipment. 3. Sterility concerns not important. 4. Only protein of interest is labeled.
Simplifies purification requirements. Often experiments can be conducted without purification. 5. Efficient labeling.
Dilution of labeled amino acid pools is minimal. 6. Toxic proteins can be produced.
Production of toxic proteins may not be possible in a cell-based system. 7. PCR products can be used as template DNA.
PCR products (linear templates) can be used in small-scale batch reactions for screening purposes. 8. Controllability.
Modified reaction conditions. Versatility of DNA source. Accessory elements can be added. Inhibitory elements can be removed.
Disadvantages Comments 1. Cost.
Commercial lysates can be expensive.
use of isotopically labeled proteins for quantitative proteomic applications. Anderson [31, 32] has taken an interesting approach by designing an artificial protein, termed polySIS, which is made up of tryptic peptides, all with C-terminal Lys, from 30 different human plasma proteins. A synthetic gene encoding the 30-peptide polySIS protein was produced, cloned into a pIVEX2.4d vector and expressed in a cell-free system with the introduction of 13 C, 15 N-Lys into the protein. The protein was purified using the twostep approach discussed previously (Ni-NTA and SEC). When this protein is cleaved with trypsin each of the resulting tryptic peptides is conveniently labeled at the C-terminus. By using the multiple reaction monitoring (MRM) capability of a triple quadrapole mass spectrometer, the absolute abundance of each protein represented in the polySIS protein can theoretically be determined. In the MRM mode, a specific transition of a precursor ion to a product ion resulting from the fragmentation of a peptide in the mass spectrometer can be monitored. This approach provides exquisite specificity and selectivity and allows the measurement of a specific peptide in a complex biological mixture. In practice, not all of the expected MRMs were observed. This could be due to incomplete tryptic proteolysis of the polySIS protein or a poor choice of candidate peptides. For this approach to be consistently applied, more optimization of the experimental details is necessary.
Another example of the use of isotopically labeled protein for quantitative proteomics is apolipoprotein E4 (ApoE4). Jin and co-workers [33] produced ApoE4 in a cell-free system with the introduction of 13 C-Arg. The labeled protein was purified by Ni-NTA chromatography and spiked into human serum as an internal standard. Following proteolysis with trypsin, 16 pairs of ApoE4 peptides from both the labeled and unlabeled protein were monitored by 52 MRMs. These workers found that both the labeled ApoE4 and the serum ApoE4 interacted equivalently with depletion adsorbants as well as with an anti-ApoE4 antibody. However, they observed a difference in ratios of labeled and unlabeled peptides from different regions of the protein, suggesting different physical forms of the labeled and endogenous forms of the protein.
An example of the use of an isotopically labeled protein, produced in a cell-based bacterial system, is the absolute quantification of alcohol dehydrogenase ADH1C1 isoenzyme in human liver [34] . In this work, the labeled protein was prepared by growing recombinant E. coli cells, harboring a plasmid for the ADH1C1 isoenzyme, in medium supplemented with 13 C, 15 N-Lys. Following the purification by Ni-NTA, the labeled protein was added as an internal standard to samples of human liver. The MRM approach, using a single MRM transition specific for the ADH1C1 isoenzyme, was applied for quantification of this isoenzyme in the presence of multiple isoforms of the enzyme.
Although the use of isotopically labeled proteins as internal standards has not been widely applied, the advantage of adding the standard to the non-processed sample is significant, if the caveats of inconsistent proteolysis due to structural differences between standard and endogenous protein are carefully considered.
